SJS Investment Consulting
SBC icon

SJS Investment Consulting’s SBC Medical Group SBC Stock Holding History

SJS Investment Consulting’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$598 Buy
121
+116
+2,320% +$434 ﹤0.01% 2697
2026
Q2 		$16 Buy
+5
New +$17 ﹤0.01% 2844

Other funds holding SBC

Lumbard & Kellner
Lumbard & Kellner Hollis, New Hampshire $352M AUM 38.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Hillsdale Investment Management
Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

SJS Investment Consulting's SBC Position: Q3 2026 in Review

SJS Investment Consulting increased its SBC Medical Group (SBC) stake by 2,320% in Q3 2026, buying an estimated $434 and bringing the position to 121 shares worth $598. The position accounts for ﹤0.01% of the portfolio, ranked #2697.

SJS Investment Consulting first reported a position in SBC in Q2 2026 and has held it in 2 quarters since. 51 funds tracked by Wall St. Rank hold SBC as of Q3 2026.

  • SJS Investment Consulting held 121 shares of SBC Medical Group worth $598 as of Q3 2026.
  • SJS Investment Consulting bought 116 SBC Medical Group shares in Q3 2026, an estimated $434.
  • SBC Medical Group made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2697 holding.
  • SJS Investment Consulting first reported a position in SBC Medical Group in Q2 2026 and has held it in 2 quarters since.
  • 51 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.